Boehringer Ingleheim's selective glucocorticoid receptor agonist development candidate: Evaluation of WO2010141331, WO2010141332 and WO2010141333

Expert Opinion on Therapeutic Patents

Volumn 21, Issue 7, 2011, Pages 1137-1142

  Norman, Peter ^a  

^a NORMAN CONSULTING   (United Kingdom)

Author keywords

asthma; COPD; glucocorticoid; glucocorticoid receptor; inhalant; process; steroid; transrepression

Indexed keywords

GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR AGONIST; HORMONE RECEPTOR STIMULATING AGENT; REAGENT; UNCLASSIFIED DRUG; WO 2010141331; WO 2010141332; WO 2010141333;

ARTICLE; CHEMICAL REACTION; CHIRALITY; CRYSTALLIZATION; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SELECTIVITY; PARTICLE SIZE; RECEPTOR AFFINITY; STEREOCHEMISTRY;

ANTI-INFLAMMATORY AGENTS; CRYSTALLIZATION; DRUG DESIGN; HUMANS; INFLAMMATION; PATENTS AS TOPIC; RECEPTORS, GLUCOCORTICOID; RESPIRATORY TRACT DISEASES; SALTS; STEREOISOMERISM;

EID: 79959471462     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2011.581229     Document Type: Article

References (15)

1. Chung KF, Caramori G, Adcock IM. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol 2009;65(9):853-71
2. Adcock IM, Caramori G, Ito K. New insights into the molecular mechanisms of corticosteroids actions. Curr Drug Targets 2006;7(6):649-60 (Pubitemid 43827260)
3. Biggadike K, Bledsoe RK, Hassell AM, et al. X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain. J Med Chem 2008;51(12):3349-52 (Pubitemid 351874991)
4. Biggadike K, Bledsoe RK, Coe DM, et al. Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor. Proc Natl Acad Sci USA 2009;106(43):18114-19
5. Schacke H, Berger M, Hansson TG, et al. Dissociated non-steroidal glucocorticoid receptor modulators: an update on new compounds Exp Opin Ther Patents 2008;18(3):339-52
6. Berlin M. Recent advances in the development of novel glucocorticoid receptor modulators. Exp Opin Ther Patents 2010;20(7):855-73
7. Kuzmich D, Kirrane T, Proudfoot J, et al. Identification of dissociated non-steroidal glucocorticoid receptor agonists. Bioorg Med Chem Lett 2007;17(18):5025-31 (Pubitemid 47259678)
8. Riether D, Harcken C, Razavi H, et al. Nonsteroidal dissociated glucocorticoid agonists containing azaindoles as steroid A-ring mimetics. J Med Chem 2010;53(18):6681-98
9. Boehringer Ingelheim International Gmbh Glucocorticoid Mimetics, Methods Of Making Them, Pharmaceutical Compositions, And Uses Thereof. WO2009149139; 2010
10. Casarosa P, Kollak I, Kiechle T, et al. Functional and biochemical rationales for the 24-hour long duration of action of olodaterol. J Pharmacol Exp Ther 2011; In press
11. Diallo H, Angell DC, Barnett HA, et al. Discovery of a potent series of non-steroidal non alpha-trifluoromethyl carbinol glucocorticoid receptor agonists with reduced lipophilicity. Bioorg Med Chem Lett 2011;21(4):1126-33
12. Bai M, Carr G, Deorazio RJ, et al. 5-Functionalized indazoles as glucocorticoid receptor agonists. Bioorg Med Chem Lett 2010;20(10):3017-20
13. Roach SL, Higuchi RI, Hudson AR, et al. Tetrahydroquinolin-3-yl carbamate glucocorticoid receptor agonists with reduced PEPCK activation. Bioorg Med Chem Lett 2011;21(6):1658-62
14. Jaroch S, Berger M, Huwe C, et al. Discovery of quinolines as selective glucocorticoid receptor agonists. Bioorg Med Chem Lett 2010;20(19):5835-8
15. Yang BV, Weinstein DS, Doweyko LM, et al. Dimethyl-diphenyl-propanamide Derivatives As Nonsteroidal Dissociated Glucocorticoid Receptor Agonists. J Med Chem 2010;53(23):8241-51